Related Experiment Video
Updated: Nov 15, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Kimberly A Morishita1, Linda Wagner-Weiner2, Eric Y Yen3
1British Columbia's Children's Hospital and the University of British Columbia, Vancouver, British Columbia, Canada.
Insights
Standardized treatment plans for severe pediatric antineutrophil cytoplasmic antibody-associated vasculitis (AAV) were established through consensus. These plans aim to facilitate future comparative effectiveness and safety studies in pediatric AAV management.
Area of Science:
- Pediatric Rheumatology
- Vasculitis Research
- Clinical Consensus
Background:
- Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) lacks standardized treatment protocols in pediatric populations.
- The rarity of pediatric AAV precludes large-scale randomized controlled trials.
- Severe pediatric AAV requires urgent and effective management strategies.
Purpose of the Study:
- To establish consensus treatment plans (CTPs) for severe pediatric AAV.
- To enable future studies on the comparative effectiveness and safety of AAV treatments.
- To provide standardized approaches for managing new-onset granulomatosis with polyangiitis, microscopic polyangiitis, and renal-limited AAV in children.
Main Methods:
- A dedicated AAV Workgroup of pediatric rheumatologists and nephrologists conducted a literature review.
- Consensus conferences utilized nominal group techniques to define treatment strategies for remission induction and maintenance.
- CARRA membership voted on the proposed CTPs, data collection, and outcome measures.
Main Results:
- Two CTPs were developed for both remission induction and maintenance of severe pediatric AAV.
- A glucocorticoid-weaning regimen, core data set, and outcome measures were defined.
- CTPs for remission induction and maintenance achieved high approval rates (94% and 98%, respectively) from CARRA membership.
Conclusions:
- Consensus methodology successfully established standardized CTPs for severe pediatric AAV.
- The developed CTPs were broadly accepted by the CARRA membership.
- These standardized plans will support pragmatic comparative effectiveness research in a long-term registry.
Objective:
There is no standardized approach to the treatment of pediatric antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Because of the rarity of pediatric AAV, randomized trials have not been feasible. The present study of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) was undertaken to establish consensus treatment plans (CTPs) for severe pediatric AAV to enable the future study of comparative effectiveness and safety.
Methods:
A workgroup of CARRA members (rheumatologists and nephrologists) formed the AAV Workgroup. This group performed a literature review on existing evidence-based treatments and guidelines for the management of AAV. They determined that the target population for CTP development was patients <18 years of age with new-onset granulomatosis with polyangiitis (GPA), microscopic polyangiitis, or renal-limited AAV (eosinophilic GPA was excluded), with presentation confined to those with severe disease (i.e., organ- or life-threatening). Face-to-face consensus conferences employed nominal group techniques to identify treatment strategies for remission induction and remission maintenance, data elements to be systematically collected, and outcomes to be measured over time.
Results:
The pediatric AAV Workgroup developed 2 CTPs for each of the remission induction and remission maintenance of severe AAV. A glucocorticoid-weaning regimen for induction and maintenance, a core data set, and outcome measures were also defined. A random sample of CARRA membership voted acceptance of the CTPs for remission induction and remission maintenance, with a 94% (75 of 80) and 98% (78 of 80) approval rate, respectively.
Conclusion:
Consensus methodology established standardized CTPs for treating severe pediatric AAV. These CTPs were in principle accepted by CARRA-wide membership for the evaluation of pragmatic comparative effectiveness in a long-term registry.
More Related Videos
09:16Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome III : Nursing Management
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care